You've used all available free searches this month | for more free features.
Clincosm LogoSign in Get a demo

Proportional Hazards

Showing 1 - 25 of 1,433
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

X-linked Adrenoleukodystrophy Trial in Beijing

Recruiting
  • X-linked Adrenoleukodystrophy
    • Beijing, China
      Beijing Tiantan Hospital
    Jul 2, 2023

    NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC Trial in China (Cadonilimab, Anlotinib, Docetaxel)

    Recruiting
    • NSCLC Stage IV
    • +2 more
    • Hefei, Anhui, China
    • +4 more
    Apr 15, 2023

    Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial (External Beam Radiation Therapy, Stereotactic Body

    Not yet recruiting
    • Stage III Prostate Cancer AJCC v8
    • Stage IVA Prostate Cancer AJCC v8
    • External Beam Radiation Therapy
    • Stereotactic Body Radiation Therapy
    • (no location specified)
    Jul 20, 2023

    Nasopharyngeal Carcinoma Trial (procedure, drug, biological)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Biospecimen Collection
    • +9 more
    • (no location specified)
    Sep 12, 2023

    Lung Non-Small Cell Squamous Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (Berzosertib, Carboplatin,

    Recruiting
    • Lung Non-Small Cell Squamous Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Los Angeles, California
    • +34 more
    Jan 20, 2023

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Metastatic Oropharyngeal Carcinoma, Recurrent Oropharyngeal Carcinoma Trial in Nashville (DNA Vaccine, Human Papillomavirus

    Not yet recruiting
    • Metastatic Oropharyngeal Carcinoma
    • Recurrent Oropharyngeal Carcinoma
    • DNA Vaccine
    • +6 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Mar 22, 2023

    Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

    Recruiting
    • Metastatic Non-Small Lung Cell Cancer
    • +4 more
    • Atlanta, Georgia
      Winship Cancer Institute of Emory University
    Oct 19, 2022

    A Study of the Effectiveness of Moderna COVID-19 Vaccine

    Recruiting
    • SARS-CoV-2
    • COVID-19
    • mRNA-1273
    • Pasadena, California
      Kaiser Permanente Southern California
    Jul 5, 2023

    Mantle Cell Lymphoma Trial (drug, biological, other, procedure)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Jul 26, 2023

    Oropharynx Cancer Trial in Philadelphia (Radiation therapy (5 days for 7 weeks), Radiation therapy (5 days for 6 weeks),

    Recruiting
    • Oropharynx Cancer
    • Radiation therapy (5 days for 7 weeks)
    • +2 more
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Apr 5, 2023

    Locally Advanced Angiosarcoma, Metastatic Angiosarcoma, Recurrent Angiosarcoma Trial in Houston (Quality-of-Life Assessment,

    Recruiting
    • Locally Advanced Angiosarcoma
    • +2 more
    • Quality-of-Life Assessment
    • Sintilimab
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Breast Carcinoma, Endometrial Carcinoma, Prostate Carcinosarcoma Trial in Philadelphia (dietary supplement, other, procedure)

    Completed
    • Breast Carcinoma
    • +2 more
    • Dietary Intervention
    • +2 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Jan 4, 2023

    Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8

    Recruiting
    • Recurrent Hepatocellular Carcinoma
    • +7 more
    • Scottsdale, Arizona
    • +1 more
    Jun 16, 2022

    Metastatic HER2-Negative Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in Nashville (Biospecimen

    Not yet recruiting
    • Metastatic HER2-Negative Breast Carcinoma
    • Metastatic Triple-Negative Breast Carcinoma
    • Biospecimen Collection
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Mar 3, 2023

    Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in

    Active, not recruiting
    • Estrogen Receptor-positive Breast Cancer
    • +9 more
    • Boston, Massachusetts
    • +1 more
    Sep 9, 2022

    Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

    Active, not recruiting
    • Refractory Non Hodgkin Lymphoma
    • Relapsed Non Hodgkin Lymphoma
    • rituximab
    • +7 more
    • Sacramento, California
      University of California Davis
    Nov 28, 2022

    High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle

    Terminated
    • High Grade Anal Canal Intraepithelial Neoplasia
    • High Grade Vulvar Squamous Intraepithelial Lesion
    • Laboratory Biomarker Analysis
    • +3 more
    • Birmingham, Alabama
    • +1 more
    Jan 24, 2023

    Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

    Not yet recruiting
    • Recurrent Glioblastoma, IDH-Wildtype
    • +2 more
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    May 13, 2023

    Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Trial in United States

    Recruiting
    • Lung Non-Small Cell Carcinoma
    • +5 more
    • San Francisco, California
    • +3 more
    Aug 17, 2022

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Houston, Texas
    • +4 more
    Oct 20, 2022

    SARS-CoV-2 Trial in Worldwide (Upamostat, Placebo (PO))

    Not yet recruiting
    • SARS-CoV-2
    • Baltimore, Maryland
    • +5 more
    Jul 19, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma Trial (other, procedure, behavioral)

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +3 more
    • Electronic Health Record Review
    • +6 more
    • (no location specified)
    Oct 27, 2023

    Locally Advanced Undifferentiated Pleomorphic Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Recurrent

    Recruiting
    • Locally Advanced Undifferentiated Pleomorphic Sarcoma
    • +3 more
    • Sintilimab
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    ALK-Positive Large B-Cell Lymphoma, Burkitt-Like Lymphoma With 11q Aberration, DLBCL Activated B-Cell Type Trial in United

    Active, not recruiting
    • ALK-Positive Large B-Cell Lymphoma
    • +34 more
    • Phoenix, Arizona
    • +32 more
    Jan 3, 2023